(Q39804103)

English

Conversion from calcineurin inhibitor to either mycophenolate mofetil or sirolimus improves renal function in liver transplant recipients with chronic kidney disease: results of a prospective randomized trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Conversion from calcineurin inhibitor to either mycophenolate mofetil or sirolimus improves renal function in liver transplant recipients with chronic kidney disease: results of a prospective randomized trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1 reference

based on heuristic

inferred from title

chronic renal insufficiency

1 reference

based on heuristic

inferred from title

Michael Olausson

4

object named as

M Olausson

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

author name string

G Herlenius

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

M Felldin

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

G Nordén

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

L Bäckman

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

B Gustafsson

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

S Friman

7

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

language of work or name

0 references

publication date

1 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

4441-4448

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Chronic renal failure after transplantation of a nonrenal organ

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.113

7 January 2021

Outcome of patients with renal insufficiency undergoing liver or liver-kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.113

7 January 2021

Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.113

7 January 2021

Management of renal dysfunction in the liver transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.113

7 January 2021

A Simple Method for the Determination of Glomerular Filtration Rate

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.113

7 January 2021

Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.113

7 January 2021

A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.113

7 January 2021

Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.113

7 January 2021

Calcineurin inhibitor minimization protocols in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.113

7 January 2021

Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.113

7 January 2021

Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.113

7 January 2021

Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.113

7 January 2021

Sirolimus conversion in liver transplant recipients with renal dysfunction: a prospective, randomized, single-center trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.113

7 January 2021

Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.113

7 January 2021

Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.113

7 January 2021

Early renal function post-liver transplantation is predictive of progressive chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.113

7 January 2021

Early kidney dysfunction post liver transplantation predicts late chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.113

7 January 2021

Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized c

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.113

7 January 2021

Nephrotoxicity of rapamycin: an emerging problem in clinical medicine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.113

7 January 2021

Sirolimus conversion for renal preservation in liver transplantation: not so fast

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.113

7 January 2021

Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.09.113

7 January 2021

Identifiers

10.1016/J.TRANSPROCEED.2010.09.113

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39804103&oldid=2090605944"